STOCKS TREAD WATER AFTER S&P 500'S RECORD CLOSE

U.S. private payrolls growth slows in June, according to ADP Employment report

Gilead Sciences, Inc. (0QYQ.IL)

IOB - IOB Delayed Price. Currency in USD

Add to watchlist

68.15

-0.23

(-0.34%)

As of 07:10PM BST. Market open.

Loading interactive chart...

Simply Wall St.
Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
GuruFocus.com
Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)
Following this sale, the insider now owns 96,380 shares of Gilead Sciences Inc. Gilead Sciences Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines. The company's portfolio includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.
ACCESSWIRE
Gilead Benefit Helps Employees Navigate Cancer Care
NORTHAMPTON, MA / ACCESSWIRE / July 1, 2024 / Jim Candler had a successful 40-year career in system operations before coming to Gilead three years ago to bring his tech expertise to the Human Resources team. "I was hired at 71 years old. What does ...